Health care negotiations lead to stock market shocks, ChuanJunshi, Cinda PD-1 has entered health insurance

Chuan Junshi, Cinda PD-1 has entered the health insuranceon the morning of the 13th, the industry's attention to PD-1 began negotiationsAlthough the results are not yet known, but the industry has reached a consensus - O medicine K medicine can not enter, but Junshi, Cinda's PD-1 is certain to enterdomestic pD-1 single resistance has 5, respectively, when the U.SSquibo O drug and MersaDong K medicine, and three other from domestic pharmaceutical companies, respectively, Junshi Bio's Tui, Cinda Bio's Dabersho, and the end of May this year approved the listing of Hengrui Pharmaceuticals ErikaAt present, it seems that Hengrui Pharmaceuticals' PD-1 because the time of listing is this year, it should be certain that there is no chance of this year's health care negotiationsSina Medicine the first time on the news to verify the relevant people, this person told us that is still waiting for the final notice, but Junshi is still very much hope to enter health insurance, because from the beginning of the pricing has been very sincereAccording to Sina Pharma previously organized, Junshi Bio Tuyi's pricing is 7200 yuan / 240mg (branch), equivalent to 30 yuan / mgThe cost of a year's treatment for patients is $187,200If the patient is eligible for a charity drug, the cost of a year's treatment can be limited to 936,000 if he or she receives the charity drugCompared with the PD-1 that has been listed in China, Junshi's pricing is relatively lowdiabetes drugs face a big drop in the price of many shares
According to a number of media reports, 12 pm has Lilly, Johnson and Johnson, Hesse and other manufacturers involved in diabetes-related drugs have walked out of the meeting, so the afternoon more focus on diabetes drugs negotiationsnews, Hesco-related varieties of negotiations failed, this morning, Haisco has been downIt is also worth noting that East China Medicine, Tonghua Dongbao and other enterprises with diabetes drugs also fell rapidly after the opening of the afternoonAccording to caixin news agency news that Tonghua Dongbao afternoon diving once fell more than 6%, or because of the health insurance diabetes drugs face a big priceand late yesterday, there was also a mention that Xi'an Yangsen's Kaglenet had been negotiatedCagle net access to health insurance, and like The Melco activeprice price reduction to caterIn April this year, Yangsen's Kaglenet (100mg x 10 pieces / box) in Chongqing, Liaoning, Gansu and other places to actively apply for price reduction, a drop of up to 40%, the specification of the hanging net price from the original 159.6 yuan per box adjustment to 96 yuanin response to the situation of on-site negotiations on the afternoon of the 12th, industry sources pointed out that the three-day negotiation time may be delayed to 15 days, but there are also credible sources, the negotiation time is still "as originally planned", if according to this time, today may conclude the negotiations, I believe that soon, the final negotiating entry list will meet with everyoneWe will continue to focus on ...